Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng Y, Li M, Xia W, Feng D, Yin R, Xu L
Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Baiziting 42, Nanjing 210009, China.
The Fourth Clinical College of Nanjing Medical University, Nanjing, 210000, China.
Cell Death Dis. 2015 Aug 20;6(8):e1858. doi: 10.1038/cddis.2015.203.
Long noncoding RNAs (lncRNAs) are known to regulate the development and progression of various cancers. However, few lncRNAs have been well characterized in lung adenocarcinoma (LUAD). Here, we identified the expression profile of lncRNAs and protein-coding genes via microarrays analysis of paired LUAD tissues and adjacent non-tumor tissues from five female non-smokes with LUAD. A total of 498 lncRNAs and 1691 protein-coding genes were differentially expressed between LUAD tissues and paired adjacent normal tissues. A novel lncRNA, LUAD transcript 1 (LUADT1), which is highly expressed in LUAD and correlates with T stage, was characterized. Both in vitro and in vivo data showed that LUADT1 knockdown significantly inhibited proliferation of LUAD cells and induced cell cycle arrest at the G0-G1 phase. Further analysis indicated that LUADT1 may regulate cell cycle progression by epigenetically inhibiting the expression of p27. RNA immunoprecipitation and chromatin immunoprecipitation assays confirmed that LUADT1 binds to SUZ12, a core component of polycomb repressive complex 2, and mediates the trimethylation of H3K27 at the promoter region of p27. The negative correlation between LUADT1 and p27 expression was confirmed in LUAD tissue samples. These data suggested that a set of lncRNAs and protein-coding genes were differentially expressed in LUAD. LUADT1 is an oncogenic lncRNA that regulates LUAD progression, suggesting that dysregulated lncRNAs may serve as key regulatory factors in LUAD progression.
已知长链非编码RNA(lncRNA)可调节多种癌症的发生发展。然而,在肺腺癌(LUAD)中,很少有lncRNA得到充分表征。在此,我们通过对五名患有LUAD的女性非吸烟患者的LUAD组织和相邻非肿瘤组织进行微阵列分析,确定了lncRNA和蛋白质编码基因的表达谱。在LUAD组织和配对的相邻正常组织之间,共有498个lncRNA和1691个蛋白质编码基因差异表达。我们鉴定了一种新型lncRNA,即LUAD转录本1(LUADT1),它在LUAD中高表达且与T分期相关。体外和体内数据均显示,敲低LUADT1可显著抑制LUAD细胞的增殖,并诱导细胞周期停滞在G0-G1期。进一步分析表明,LUADT1可能通过表观遗传抑制p27的表达来调节细胞周期进程。RNA免疫沉淀和染色质免疫沉淀试验证实,LUADT1与多梳抑制复合物2的核心成分SUZ12结合,并介导p27启动子区域H3K27的三甲基化。在LUAD组织样本中证实了LUADT1与p27表达之间的负相关。这些数据表明,一组lncRNA和蛋白质编码基因在LUAD中差异表达。LUADT1是一种调节LUAD进展的致癌lncRNA,这表明失调的lncRNA可能是LUAD进展中的关键调节因子。